You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HBeAg

Showing 1 - 25 of 632
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatitis B Trial in Guangzhou (NrtIs, HH-003, HH-003+NrtIs)

Active, not recruiting
  • Chronic Hepatitis B
  • Guangzhou, Guangdong, China
    Nanfang Hospital, Southern Medical University
Apr 20, 2023

HBeAg-negative CHB Patients With Indeterminate Phase

Recruiting
  • Chronic Hepatitis b
  • Observation
  • Antiviral treatment
  • Changzhou, Jiangsu, China
  • +4 more
Dec 21, 2022

Chronic Hepatitis B Trial (PEG IFN a-2b; TAF)

Not yet recruiting
  • Chronic Hepatitis B
  • PEG IFN α-2b; TAF
  • (no location specified)
Aug 5, 2022

Chronic Hepatitis B Virus Infection Trial in Kaohsiung, Taichung, Taipei (Ropeginterferon alfa-2b, Entecavir)

Recruiting
  • Chronic Hepatitis B Virus Infection
  • Kaohsiung, Taiwan
  • +4 more
Aug 12, 2022

HBe Negative Chronic Hepatitis B, Hepatitis B Viral Infection Trial in Marseille (CLEVUDINE + TENOFOVIR PLACEBO, CLEVUDINE IN

Terminated
  • HBe Negative Chronic Hepatitis B
  • Hepatitis B Viral Infection
  • CLEVUDINE + TENOFOVIR PLACEBO
  • +2 more
  • Marseille, France
    Hôpital Saint Joseph
Jan 30, 2023

Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, JNJ-64300535, ETV monohydrate)

Active, not recruiting
  • Hepatitis B, Chronic
  • Edegem, Belgium
  • +12 more
Jan 17, 2023

Hepatitis B Virus - Chronic Active Trial (Fumarate, Tenofovir Disoproxil)

Not yet recruiting
  • Hepatitis B Virus - Chronic Active
  • Fumarate, Tenofovir Disoproxil
  • (no location specified)
May 28, 2022

Hepatitis B, Chronic Trial in Beijing (Hepalatide 2.1mg, Hepalatide 4.2mg, Hepalatide 6.3mg)

Recruiting
  • Hepatitis B, Chronic
  • Hepalatide 2.1mg
  • +6 more
  • Beijing, Beijing, China
    The fifth medical center of PLA
Nov 23, 2021

CHRONIC HEPATITIS B Trial in Hô` Chi´ Minh (CTH Chronic Hepatitis B)

Approved for marketing
  • CHRONIC HEPATITIS B
  • CTH Chronic Hepatitis B
  • Hồ Chí Minh, Ho Chi Minh City, Vietnam
    Saigon Biopharma Company Limited
Oct 6, 2021

TAF for 48 Weeks in HBeAg Positive CHB Patients

Recruiting
  • Chronic Hepatitis B
  • Tenofovir Alafenamide 25 MG [Vemlidy]
  • Shanghai, China
  • +2 more
Sep 5, 2021

Chronic Hepatitis B Trial in Zhengzhou (PegIFN a- 2b)

Completed
  • Chronic Hepatitis B
  • PegIFN α- 2b
  • Zhengzhou, Henan, China
    Henan Provincial People's Hospital
Jul 11, 2022

Chronic Hepatitis Trial in Hangzhou, Shanghai (Group A, TDF, Group B:TDF then TDF and Peginterferon alfa-2a, Group C:TDF and

Recruiting
  • Chronic Hepatitis
  • Group A, TDF
  • +2 more
  • Hangzhou, China
  • +7 more
Sep 21, 2021

Hepatocellular Carcinoma Trial in Hong Kong (Durvalumab, Sorafenib, Lenvatinib)

Recruiting
  • Hepatocellular Carcinoma
  • Hong Kong, Hong Kong SAR, Hong Kong
    Humanity & Health Research Centre
Mar 16, 2022

Chronic Hepatitis B Trial (Bepirovirsen, Placebo)

Recruiting
  • Chronic Hepatitis B
  • Herston, Queensland, Australia
  • +7 more
Jan 23, 2023

Chronic Hepatitis B Trial in Guangzhou (TDF, Tenofovir Disoproxil Fumarate 300 MG)

Recruiting
  • Chronic Hepatitis B
  • TDF
  • Tenofovir Disoproxil Fumarate 300 MG
  • Guangzhou, China
    Chaoshuang Lin
Jan 8, 2021

Chronic Hepatitis B Trial in Worldwide (Bepirovirsen, Placebo)

Recruiting
  • Chronic Hepatitis B
  • Victoria, British Columbia, Canada
  • +10 more
Jan 23, 2023

Chronic Hepatitis B Trial in Singapore (Placebo Oral Tablet, Nitazoxanide)

Active, not recruiting
  • Chronic Hepatitis B
  • Singapore, Singapore
    National University Hospital
Feb 5, 2021

HBeAg Positive Chronic Hepatitis B Trial in Beijing (NAs+IFN-a)

Not yet recruiting
  • HBeAg Positive Chronic Hepatitis B
  • Beijing, Beijing, China
    Min Zhang
Sep 28, 2020

Hepatitis B, Chronic Trial in Worldwide (IMC-I109V-101 Single Ascending Dose, IMC-I109V-101 Multiple Ascending Doses)

Recruiting
  • Hepatitis B, Chronic
  • IMC-I109V-101 Single Ascending Dose
  • IMC-I109V-101 Multiple Ascending Doses
  • Los Angeles, California
  • +19 more
May 10, 2023

Hepatitis B, Chronic Trial in Worldwide (peginterferon alfa-2a [Pegasys])

Completed
Has Results
  • Hepatitis B, Chronic
  • peginterferon alfa-2a [Pegasys]
  • San Francisco, California
  • +38 more
Oct 26, 2022

Predictive Model for Prognosis of Chronic HBV Infection Mothers

Recruiting
  • Hepatitis B, Chronic
  • Age, BMI,Baseline HBV DNA, Baseline HBeAg level, Baseline HBsAg level, Antiviral treatment, Serum ALT level
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xi'an Jiaotong University
Aug 20, 2021

Chronic HBV Infection Trial in China (HH-003 injection, Placebo)

Completed
  • Chronic HBV Infection
  • HH-003 injection
  • Placebo
  • Beijing, Beijing, China
  • +10 more
Sep 14, 2022

Hepatitis B, Interferon Trial (Interferon, Interferon+resveratrol)

Completed
  • Hepatitis B
  • Interferon
  • (no location specified)
Oct 10, 2020

Chronic Hepatitis B Trial in Amsterdam (Peg-Interferon alfa 2a + Adefovir dipivoxil, Peg-Interferon alfa 2a + Tenofovir

Completed
  • Chronic Hepatitis B
  • Peg-Interferon alfa 2a + Adefovir dipivoxil, Peg-Interferon alfa 2a + Tenofovir disoproxil fumarate
  • Amsterdam, Noord-Holland, Netherlands
    Academic Medical Center
Mar 25, 2021

Hepatitis B, Chronic Trial in Worldwide (Stop of therapy)

Active, not recruiting
  • Hepatitis B, Chronic
  • Stop of therapy
  • København, Denmark
  • +10 more
Sep 13, 2021